$281.4M in expenses

Vaccine and infectious disease division (vidd): vidd integrates the latest in computational, laboratory and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Vidd researchers partner with scientists at laboratory, clinical and field sites in the americas, africa, asia and europe. The division has specific initiatives in uganda, china and the republic of south africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions. Vidd scientists around the world, including clinicians, clinical trial specialists, statisticians, computational biologists and basic scientists, take pride in their collaborative efforts to predict, detect, treat and prevent infectious diseases in humans, including known and emerging infections of major global health importance, such as coronavirus, and cancer-related infectious diseases.

$120.1M in expenses

Clinical research division:the clinical research division conducts laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our clinical researchers are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.

$87.5M in expenses

Public health sciences division:the public health sciences division identifies strategies that would ultimately reduce the incidence of and mortality from cancer and other diseases. Using large populations as their "laboratory," our public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors. Identifying such cancer causes can lead to better cancer-detection methods and new ways to help people adopt healthier lifestyles to minimize or avoid their risk of getting the disease in the first place. Our statistical, computational, epidemiological, translational and prevention projects include studies around the world.

$36.7M in expenses

Human biology division:the human biology division integrates fundamental, applied and translational science to improve the diagnosis, treatment and prevention of cancer and other diseases. Human biology researchers come together to form a multidisciplinary team that is influenced by individual advances. Their diverse expertise include molecular and cell biology, genomics, genetics, virology, infectious disease, computational biology, pathology and clinical research. Grounded in high-quality basic science, the research performed in human biology blends research performed in model organisms and in vitro systems.

$26.9M in expenses

Basic sciences division:the basic sciences division answers fundamental biological questions and produces new insights on the basic biology of life processes and the development of complex diseases like cancer. Our faculty include investigators working in diverse areas related to all aspects of biology, including gene regulation and genomic integrity, neuroscience, immunology and evolution, biophysics and quantitative biology, and cell proliferation and fate.